CSPC Pharmaceutical Group Ltd  

(Public, HKG:1093)   Watch this stock  
Find more results for doxorubicin
-0.11 (-1.82%)
Aug 1 - Close
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range 5.89 - 6.06
52 week 3.71 - 8.49
Open 6.00
Vol / Avg. 7.88M/14.30M
Mkt cap 33.07B
P/E 34.45
Div/yield 0.08/1.35
EPS 0.17
Shares 5.91B
Beta     -
Inst. own     -
Aug 25, 2014
Interim 2014 CSPC Pharmaceutical Group Ltd Earnings Release (Estimated) Add to calendar
Jul 16, 2014
CSPC Pharmaceutical Group Ltd at Bank of America Merrill Lynch Healthcare Corporate Day
Jul 8, 2014
CSPC Pharmaceutical Group Ltd at Citi Hong Kong and China Corporate Day (Theme: Healthcare)
May 23, 2014
Q1 2014 CSPC Pharmaceutical Group Ltd Earnings Release
May 20, 2014
CSPC Pharmaceutical Group Ltd Annual Shareholder Meeting
May 19, 2014
CSPC Pharmaceutical Group Ltd at Deutsche Bank dbAccess Asia Conference

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin 10.29% 9.94%
Operating margin 13.92% 13.41%
EBITD margin - 18.43%
Return on average assets - 7.64%
Return on average equity - 13.86%
Employees 10,390 -
CDP Score - -


Room 3805 38 Floor, Central Plaza 18 Harbour Road Wanchai
Hong Kong
+852-2-8023011 (Phone)
+852-2-8024552 (Fax)

Website links


CSPC Pharmaceuticals Group Ltd., formerly China Pharmaceutical Group Limited, is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacture and sale of pharmaceutical products. The Company is operating in three business segments: manufacture and sale of intermediate and bulk drugs, including vitamin C series and antibiotics series; finished drugs, including amoxicillin and cefazolin in different dosage and form, and other pharmaceutical related business and development activities. As of December 31, 2011, its subsidiaries included Golden Wing Limited, Tin Lon Investment Limited, CSPC Zhongrun Pharmaceutical (Inner Mongolia) Co.,Ltd., CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Inner Mongolia Zhongxingyuan Sewage Treatment Co.,Ltd and others. On July 18, 2013, the Company disposed a direct wholly-owned subsidiary.

Officers and directors

Dongchen Cai Executive Chairman of the Board, Chief Executive Officer
Age: 58
Kin Man Chak Executive Director
Age: 46
Zhenying Feng Executive Director
Age: 56
Jianmin Lu Executive Director
Age: 53
Weidong Pan Executive Director
Age: 42
Huaiyu Wang Executive Director
Age: 49
Jinxu Wang Executive Director
Age: 42
Shunlong Wang Executive Director
Zhenguo Wang Executive Director
Age: 43
Huan Zhao Executive Director
Age: 50